MedTrace Logo

A Pilot Clinical Trial of Pyruvate, Creatine, and Niacinamide in Progressive Supranuclear Palsy.

NCT00605930 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 20

Last updated 2017-04-10

No results posted yet for this study

Summary

This study intends to study the safety and tolerance of the combination of pyruvate, creatine, and niacinamide over 6 months in patients with PSP.

Conditions

Interventions

DIETARY_SUPPLEMENT

Pyruvate, creatine, niacinamide

A bar of 2 gm of pyruvate and 1 gm of creatine, and a pill of 1 gm of niacinamide once a day for 24 weeks.

DIETARY_SUPPLEMENT

Placebo

25% of subjects will receive a placebo bar and a placebo pill once a day for 24 weeks.

Sponsors & Collaborators

  • University of Louisville

    lead OTHER

Principal Investigators

  • Irene Litvan, MD · University of Louisville, Division of Movement Disorders

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2004-04-30
Primary Completion
2009-12-31
Completion
2009-12-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00605930 on ClinicalTrials.gov